Financial Perspectives’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Financial Perspectives’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-56	Closed	-$12.1K	–	665
2021 Q1	$12.1K	Hold	56	–	–	0.01%	424
2020 Q4	$6.46K	Hold	56	–	–	﹤0.01%	448
2020 Q3	$5.45K	Hold	56	–	–	﹤0.01%	411
2020 Q2	$6.87K	Sell	56 -50	-47%	-$5.67K	﹤0.01%	381
2020 Q1	$9.28K	Hold	106	–	–	0.01%	332
2019 Q4	$11.1K	Buy	+106	New	+$11.9K	0.01%	322

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Financial Perspectives's GWPH Position: Q2 2021 in Review

Financial Perspectives sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 56 shares — an estimated $12.1K sold.

Financial Perspectives first reported a position in GWPH in Q4 2019 and held it in 6 quarters. The position peaked at $12.1K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Financial Perspectives reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Financial Perspectives sold 56 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $12.1K.
Financial Perspectives first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 6 quarters.
Financial Perspectives's GW Pharmaceuticals Plc American Depositary Shares position peaked at $12.1K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Financial Perspectives's 13F filing for Q2 2021, filed 10 Jan 2024.